Stock Observer logo

The Latest Headlines at Stock Observer

Image about Centrus Energy Corp. (NYSE:LEU) Receives $246.17 Consensus Price Target from Analysts

Centrus Energy Corp. (NYSE:LEU) Receives $246.17 Consensus Price Target from Analysts

Shares of Centrus Energy Corp. (NYSE:LEU – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Seven analysts... More of this article »
Image about Brokerages Set TeraWulf Inc. (NASDAQ:WULF) Price Target at $34.74

Brokerages Set TeraWulf Inc. (NASDAQ:WULF) Price Target at $34.74

TeraWulf Inc. (NASDAQ:WULF – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty research firms that are covering the firm, MarketBeat.com reports. One equities research analyst... More of this article »
Image about Group 1 Automotive, Inc. (NYSE:GPI) Receives $400.22 Consensus Target Price from Analysts

Group 1 Automotive, Inc. (NYSE:GPI) Receives $400.22 Consensus Target Price from Analysts

Shares of Group 1 Automotive, Inc. (NYSE:GPI – Get Free Report) have received an average recommendation of “Hold” from the ten analysts that are covering the company, Marketbeat reports. One equities research analyst... More of this article »
Image about FirstSun Capital Bancorp (NASDAQ:FSUN) Upgraded to “Buy” at Wall Street Zen

FirstSun Capital Bancorp (NASDAQ:FSUN) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of FirstSun Capital Bancorp (NASDAQ:FSUN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. A number of other research analysts also recently... More of this article »
Image about Figure Technology Solutions (NASDAQ:FIGR) Rating Increased to Hold at Wall Street Zen

Figure Technology Solutions (NASDAQ:FIGR) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Figure Technology Solutions (NASDAQ:FIGR – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Other analysts have also issued research reports... More of this article »
Image about Draganfly (NASDAQ:DPRO) Downgraded by Wall Street Zen to Strong Sell

Draganfly (NASDAQ:DPRO) Downgraded by Wall Street Zen to Strong Sell

Wall Street Zen lowered shares of Draganfly (NASDAQ:DPRO – Free Report) from a sell rating to a strong sell rating in a research note published on Saturday. Other analysts have also issued reports about the company. Needham &... More of this article »
Image about Motorcar Parts of America (NASDAQ:MPAA) Downgraded by Wall Street Zen to “Hold”

Motorcar Parts of America (NASDAQ:MPAA) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen lowered shares of Motorcar Parts of America (NASDAQ:MPAA – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Saturday. Other research analysts have also issued research... More of this article »
Image about Jianzhi Education Technology Group (NASDAQ:JZ) Upgraded to “Hold” at Wall Street Zen

Jianzhi Education Technology Group (NASDAQ:JZ) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Jianzhi Education Technology Group (NASDAQ:JZ – Free Report) from a sell rating to a hold rating in a research report released on Saturday. Separately, Weiss Ratings reaffirmed a “sell... More of this article »
Image about Moleculin Biotech (NASDAQ:MBRX) Upgraded to Sell at Wall Street Zen

Moleculin Biotech (NASDAQ:MBRX) Upgraded to Sell at Wall Street Zen

Wall Street Zen upgraded shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) from a strong sell rating to a sell rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings reissued a “sell... More of this article »
Image about Omeros (NASDAQ:OMER) Rating Increased to Buy at Wall Street Zen

Omeros (NASDAQ:OMER) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Omeros (NASDAQ:OMER – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. OMER has been the subject of a number of other reports. Weiss Ratings... More of this article »
Image about Ovid Therapeutics (NASDAQ:OVID) Upgraded to Hold at Wall Street Zen

Ovid Therapeutics (NASDAQ:OVID) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Ovid Therapeutics (NASDAQ:OVID – Free Report) from a sell rating to a hold rating in a report issued on Saturday. Other equities research analysts have also issued research reports about the... More of this article »
Image about Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to “Strong Sell”

Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to “Strong Sell”

Wall Street Zen downgraded shares of Nkarta (NASDAQ:NKTX – Free Report) from a sell rating to a strong sell rating in a report released on Saturday morning. Several other brokerages have also recently weighed in on NKTX. Evercore... More of this article »
Image about ProQR Therapeutics (NASDAQ:PRQR) Rating Increased to Hold at Wall Street Zen

ProQR Therapeutics (NASDAQ:PRQR) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) from a strong sell rating to a hold rating in a research note published on Saturday. A number of other research analysts have also recently issued... More of this article »
Image about Carisma Therapeutics (CARM) Expected to Announce Earnings on Monday

Carisma Therapeutics (CARM) Expected to Announce Earnings on Monday

Carisma Therapeutics (NASDAQ:CARM – Get Free Report) is expected to be posting its resultson Monday, August 17th. Analysts expect the company to post earnings of ($0.1139) per share and revenue of $4.2290 million for the quarter.... More of this article »
Image about Presidio Production (NYSE:FTW) Upgraded to “Hold” at Wall Street Zen

Presidio Production (NYSE:FTW) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Presidio Production (NYSE:FTW – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other analysts also recently weighed in on FTW. Zacks... More of this article »